Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer
Alexey S. Revenko, Larissa S. Carnevalli, Charles Sinclair, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e003892-e003892
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Regulatory cells and the effect of cancer immunotherapy
María Iglesias-Escudero, Noelia Arias-González, Eva Martínez‐Cáceres
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 111
Fungi, immunosenescence and cancer
Bin Xu, Zan Luo, Xing Niu, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 67-82
Closed Access | Times Cited: 4
Regulatory T cells in immune checkpoint blockade antitumor therapy
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
MAPK and STAT3 Inhibitors Modulate FoxP3 Expression and Regulatory T Cell Function
Nuria García‐Díaz, Elise Solli, Ehsan Hajjar, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 2
Closed Access | Times Cited: 1
Advanced applications of DNA nanostructures dominated by DNA origami in antitumor drug delivery
Yiming Zhang, Xinchen Tian, Zijian Wang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 21
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside
Elif Çakan, Olivia D. Lara, Anna Szymanowska, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2940-2940
Open Access | Times Cited: 6
Steering research on mRNA splicing in cancer towards clinical translation
Olga Anczuków, Frédéric H.‐T. Allain, Brittany Angarola, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 12, pp. 887-905
Closed Access | Times Cited: 6
Strategies for Heating Up Cold Tumors to Boost Immunotherapies
Daniel J. Zabransky, Mark Yarchoan, Elizabeth M. Jaffee
Annual Review of Cancer Biology (2023) Vol. 7, Iss. 1, pp. 149-170
Closed Access | Times Cited: 16
STAT6-targeting antisense oligonucleotides against solitary fibrous tumor
Yi Li, José L. Mondaza-Hernández, David S. Moura, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102154-102154
Open Access | Times Cited: 5
Regulatory T-cells: The Face-off of the Immune Balance
Mahmoud Singer, Ahmed M. Elsayed, Mohamed I. Husseiny
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 11
Open Access | Times Cited: 5
Harnessing the biology of regulatory T cells to treat disease
Christine M. Wardell, Dominic A. Boardman, Megan K. Levings
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 5
Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer
Stéphane Fattori, Hugo Roux, Emilie Connen, et al.
Cancer Research (2022) Vol. 82, Iss. 21, pp. 3868-3879
Closed Access | Times Cited: 19
The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression
Yu-ting Zou, Jinyuan Li, Jun-yi Chai, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 707, pp. 149513-149513
Closed Access | Times Cited: 4
Advances in targeting tumor microenvironment for immunotherapy
Lugang Wang, Liubo Zhang, Zhen Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies
Chang Zhu, J Liao, Yiyang Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Identification of a group of 9-amino-acridines that selectively down-regulate regulatory T cell functions through FoxP3
Wei Qian, Håvard Foyn, Johannes Landskron, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 111931-111931
Open Access
Tumor immunophenotypic correlates in patients aged 80 years or older with non-small cell lung cancer and outcomes to first-line pembrolizumab in PD-L1 high (≥50%) patients
Adriana P C Barrichello, Arielle Elkrief, Biagio Ricciuti, et al.
Clinical Lung Cancer (2025)
Closed Access
Lanatoside C activates the E3 ligase STUB1 to inhibit FOXP3 transcriptional activity and promote antitumor immunity
Qian Zhou, Tong Yang, Yushu Shi, et al.
EMBO Molecular Medicine (2025)
Open Access
The clinical significance of T-cell regulation in hypertension treatment
Miaoxin Fu, Ming Lv, Jinyue Guo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Alternative Splicing: A Key Regulator in T cell Response and Cancer Immunotherapy
C.-C. Yong, Yexin Liang, Minmin Wang, et al.
Pharmacological Research (2025), pp. 107713-107713
Open Access
Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies
Tudor-Paul Tamaș, Elena Ciurariu
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3535-3535
Open Access
Targeting Foxp3 in Glioblastoma: Blockade of Tumor Intrinsic Effects Boosts Response to Chemo-Radiotherapy
Matías Garcia Fallit, Jorge A. Peña Agudelo, Alejandro J. Nicola Candia, et al.
(2025)
Closed Access
Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?
Yaqin Li
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
FoxP3 Expression in Tumor-Infiltrating Lymphocytes as Potential Predictor of Response to Immune Checkpoint Inhibitors in Patients with Advanced Melanoma and Non-Small Cell Lung Cancer
Peter Grell, Simona Bořilová, Pavel Fabián, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1901-1901
Open Access | Times Cited: 9
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells
Libao Liu, Laurie Rangan, Nathan Vanalken, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top